UBS Oncology Impact Fund L.P.
Related Filers (15)
- BioImpact Capital LLC (54)
- Oncology Impact Fund (Cayman) Management L.P. (54)
- GADICKE ANSBERT (35)
- MPM Oncology Impact Management GP LLC (32)
- iTeos Therapeutics, Inc. (20)
- Harpoon Therapeutics, Inc. (15)
- Cullinan Oncology, Inc. (12)
- Spring Bank Pharmaceuticals, Inc. (4)
- SUNESIS PHARMACEUTICALS INC (4)
- MEI Pharma, Inc. (3)
- TCR2 THERAPEUTICS INC. (2)
- Oncorus, Inc. (2)
- Werewolf Therapeutics, Inc. (2)
- MPM ONCOLOGY INNOVATIONS FUND LP (2)
- MPM Oncology Innovations Fund GP LLC (2)
- Show More ...
Ownership (64)
SC 13G/A
Thursday, 2/9/2023
MEI Pharma, Inc.: Major Shareholders
4
Thursday, 1/6/2022
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/7/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/2/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/30/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/24/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/18/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/14/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/12/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/5/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/30/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/27/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/23/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/20/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/20/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/16/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/16/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/13/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/13/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/8/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/8/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/2/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/31/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/25/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/12/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/2/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/27/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/24/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/17/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/12/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/6/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/6/2021
Werewolf Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/4/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/29/2021
Werewolf Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/29/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/22/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/20/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/15/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/13/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/13/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/9/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/16/2021
MEI Pharma, Inc.: Major Shareholders
SC 13D
Tuesday, 1/19/2021
Cullinan Management, Inc.: Major Shareholders
3/A
Thursday, 1/14/2021
Cullinan Management, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 1/14/2021
Cullinan Management, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 1/7/2021
Cullinan Management, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 10/8/2020
Oncorus, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/1/2020
Oncorus, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/30/2020
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
iTeos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Wednesday, 4/8/2020
Spring Bank Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/5/2020
SUNESIS PHARMACEUTICALS INC: Major Shareholders
SC 13G
Wednesday, 2/5/2020
MEI Pharma, Inc.: Major Shareholders
4
Thursday, 2/21/2019
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/14/2019
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/13/2019
TCR2 THERAPEUTICS INC.: Initial statement of beneficial ownership of securities
3
Thursday, 2/7/2019
Harpoon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 2/6/2018
Spring Bank Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/6/2018
Spring Bank Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/6/2018
SUNESIS PHARMACEUTICALS INC: Major Shareholders
4
Monday, 11/6/2017
SUNESIS PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/31/2017
SUNESIS PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
SC 13G
Monday, 12/5/2016
Spring Bank Pharmaceuticals, Inc.: Major Shareholders